AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 16, 2026

Daily Signals

2761 companies scored · Alpha · vs marketSwitch to Total · 30D 90D

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run
Companies scored 2761 IC ≥ 0 · market cap ≥ $100M
Median forecast -0.24% Alpha · 30D
Long–short spread +2.33% Strong Buy minus Strong Sell, mean
Median IC 0.17 Spearman · 30D
Rating changes ▲ 524 ▼ 494 vs the previous run
Cross-section

Distribution of the day's forecasts

30D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

2761 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
2501 FFFutureFuel Corp. Industrial Applications and Services -0.03 $248M Unlock rating and forecasts
2502 CATXPerspective Therapeutics, Inc. Life Sciences 0.08 $248M Unlock rating and forecasts
2503 EFSIEAGLE FINANCIAL SERVICES INC Finance 0.35 $248M Unlock rating and forecasts
2504 NPWRNet Power Inc. Manufacturing -0.05 $247M Neutral -0.14% -0.24% ·
2505 STRTSTRATTEC SECURITY CORP Manufacturing 0.10 $247M Neutral -0.36% -0.75% ·
2506 LFCRLIFECORE BIOMEDICAL, INC. \DE\ Life Sciences 0.08 $244M Neutral -0.37% -0.77% ▲ 1
2507 HQIHireQuest, Inc. Trade & Services 0.20 $243M Unlock rating and forecasts
2508 JACKJACK IN THE BOX INC Trade & Services 0.21 $243M Unlock rating and forecasts
2509 PEBKPEOPLES BANCORP OF NORTH CAROLINA INC Finance 0.16 $241M Neutral -0.11% -0.18% ·
2510 GRRRGorilla Technology Group Inc. Technology 0.03 $241M Unlock rating and forecasts
2511 REFIChicago Atlantic Real Estate Finance, Inc. Real Estate & Construction 0.03 $241M Neutral -0.33% -0.68% ▲ 1
2512 TLSITriSalus Life Sciences, Inc. Industrial Applications and Services 0.14 $240M Unlock rating and forecasts
2513 ABEOABEONA THERAPEUTICS INC. Life Sciences -0.01 $240M Unlock rating and forecasts
2514 PPIHPerma-Pipe International Holdings, Inc. Technology 0.07 $240M Unlock rating and forecasts
2515 CABACabaletta Bio, Inc. Life Sciences -0.02 $239M Unlock rating and forecasts
2516 UTMDUTAH MEDICAL PRODUCTS INC Industrial Applications and Services 0.21 $239M Neutral -0.42% -0.92% ·
2517 AIVAPARTMENT INVESTMENT & MANAGEMENT CO Real Estate & Construction 0.44 $238M Neutral -0.40% -0.88% ▲ 1
2518 AMRNAMARIN CORP PLC\UK Life Sciences 0.13 $238M Unlock rating and forecasts
2519 IMMRIMMERSION CORP Technology 0.20 $237M Neutral -0.38% -0.79% ▲ 1
2520 SABSSAB Biotherapeutics, Inc. Life Sciences 0.30 $236M Neutral -0.09% -0.14% ·
2521 IMRXImmuneering Corp Life Sciences 0.30 $235M Unlock rating and forecasts
2522 KGEIKolibri Global Energy Inc. Energy & Transportation 0.27 $235M Neutral -0.29% -0.57% ▲ 1
2523 CMTVCOMMUNITY BANCORP /VT Finance 0.07 $234M Unlock rating and forecasts
2524 GWRSGlobal Water Resources, Inc. Energy & Transportation -0.09 $233M Neutral -0.23% -0.44% ·
2525 NEGGNewegg Commerce, Inc. Trade & Services -0.21 $233M Neutral -0.11% -0.18% ·
2526 AENTALLIANCE ENTERTAINMENT HOLDING CORP Trade & Services 0.40 $231M Unlock rating and forecasts
2527 FATEFATE THERAPEUTICS INC Life Sciences 0.05 $231M Unlock rating and forecasts
2528 PROFProfound Medical Corp. Industrial Applications and Services 0.13 $231M Unlock rating and forecasts
2529 EXFYExpensify, Inc. Technology 0.34 $230M Unlock rating and forecasts
2530 SIGASIGA TECHNOLOGIES INC Life Sciences 0.35 $229M Unlock rating and forecasts
2531 XPOFXponential Fitness, Inc. Trade & Services 0.30 $228M Unlock rating and forecasts
2532 SMRTSmartRent, Inc. Technology -0.05 $228M Unlock rating and forecasts
2533 AOUTAmerican Outdoor Brands, Inc. Manufacturing 0.01 $228M Unlock rating and forecasts
2534 FORRFORRESTER RESEARCH, INC. Trade & Services 0.32 $227M Unlock rating and forecasts
2535 ASLEAerSale Corp Trade & Services 0.19 $227M Neutral -0.32% -0.64% ·
2536 ZSQRZ Squared Inc. Finance or Crypto Assets 0.21 $227M Unlock rating and forecasts
2537 INBKFirst Internet Bancorp Finance 0.12 $227M Unlock rating and forecasts
2538 LXEOLexeo Therapeutics, Inc. Life Sciences -0.12 $226M Unlock rating and forecasts
2539 XPERAdeia Inc. Technology -0.05 $225M Unlock rating and forecasts
2540 GLSIGreenwich LifeSciences, Inc. Life Sciences 0.12 $225M Unlock rating and forecasts
2541 SPOKSpok Holdings, Inc Technology 0.20 $224M Neutral -0.13% -0.23% ·
2542 ASYSAMTECH SYSTEMS INC Technology 0.12 $224M Neutral -0.10% -0.16% ·
2543 MBIMBIA INC Finance 0.19 $224M Unlock rating and forecasts
2544 SVCOSilvaco Group, Inc. Technology 0.43 $223M Unlock rating and forecasts
2545 ONITONITY GROUP INC. Finance 0.13 $223M Unlock rating and forecasts
2546 NATRNATURES SUNSHINE PRODUCTS INC Life Sciences 0.41 $222M Unlock rating and forecasts
2547 UXINUxin Ltd Trade & Services 0.14 $222M Unlock rating and forecasts
2548 BIOABioAge Labs, Inc. Life Sciences 0.32 $222M Unlock rating and forecasts
2549 OPBKOP Bancorp Finance -0.01 $222M Unlock rating and forecasts
2550 KROSKeros Therapeutics, Inc. Life Sciences 0.26 $220M Neutral -0.04% -0.04% ·
2501–2550 of 2761 Previous Next
Since the previous run

Rating changes

▲ 524▼ 494
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.